EUVIMEDEUVIMED entdecken
Fallbericht

Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report

Leticia Cuñetti, Florencia Oricchio, Marta Vázquez, Raquel Peyraube, Laura Manzo, Catheryn Nalerio, Lilian Curi, Cecilia Maldonado

Transplantation Proceedings · 2024-01 · 56 (1) · 252-256

DOI: 10.1016/j.transproceed.2023.11.013 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2024-01. Verfasst von Leticia Cuñetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Transplant Unit, Nephrology and Urology Institute, Montevideo, Uruguay. Hauptthemen laut MEDLINE: Cannabidiol, Chronic Pain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney transplantation remains the optimal therapy for many patients with end-stage kidney disease (ESKD). Chronic pain is one of the most common and distressing symptoms among patients with ESKD, and its treatment is a complex and challenging task to accomplish. The benefits of cannabidiol (CBD) in chronic pain treatment have been reported recently. Cannabidiol is metabolized by cytochrome P450, mainly CYP3A4 and CYP2C19, and can also undergo direct conjugation via UDP-glucuronosyltransferase enzymes, with a growing body of evidence suggesting it is also a potent inhibitor or inducer of these pathways. Cannabidiol was also found to be a potent inhibitor of carboxylesterases in vitro. Because cytochrome P450 enzymes and carboxylesterases are also responsible for the clearance and activation of immunosuppressants, respectively, drug-drug interactions are likely to occur. Here, we report a pharmacokinetic drug interaction between CBD and cyclosporine and mycophenolate mofetil in a patient with ESKD with a kidney transplantation. It is thus crucial to take into account these interactions and monitor drug levels to avoid drug toxicity or a lack of efficacy. This study is in accordance with the guidelines of the Declaration of Helsinki and the Declaration of Istanbul.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolChronic PainHumansCyclosporineMycophenolic AcidCytochrome P-450 Enzyme SystemDrug InteractionsCarboxylic Ester Hydrolases

Substanzen

CyclosporineCannabidiolMycophenolic AcidCytochrome P-450 Enzyme SystemCarboxylic Ester Hydrolases

Autor:innen und Institutionen

  • Kidney Transplant Unit, Nephrology and Urology Institute, Montevideo, Uruguay.
  • Graduate Program in Chemistry, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay.
  • Pharmaceutical Sciences Department, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay.
  • International Diploma in Endocannabinology Cannabis and Cannabinoids, Instituto de Investigaciones Biológicas Clemente Estable-MEC, Montevideo, Uruguay.
  • Pharmaceutical Sciences Department, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay. Electronic address: cmaldonado@fq.edu.uy.

Zitieren

APA

Cuñetti, L., Oricchio, F., Vázquez, M., Peyraube, R., Manzo, L., Nalerio, C., Curi, L., & Maldonado, C. (2024). Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report. Transplantation Proceedings, 56(1), 252-256. https://doi.org/10.1016/j.transproceed.2023.11.013

Vancouver

Cuñetti L, Oricchio F, Vázquez M, Peyraube R, Manzo L, Nalerio C, et al. Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report. Transplantation Proceedings. 2024;56(1):252-256. doi:10.1016/j.transproceed.2023.11.013

BibTeX
@article{Cuetti2024,
  author = {Cuñetti, Leticia and Oricchio, Florencia and Vázquez, Marta and Peyraube, Raquel and Manzo, Laura and Nalerio, Catheryn and Curi, Lilian and Maldonado, Cecilia},
  title = {Drug-Drug Interaction Between Cannabidiol, Cyclosporine, and Mycophenolate Mofetil: A Case Report},
  journal = {Transplantation Proceedings},
  year = {2024},
  volume = {56},
  number = {1},
  pages = {252--256},
  doi = {10.1016/j.transproceed.2023.11.013}
}
Kostenlos starten →